Literature DB >> 17707357

Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists?

Terence E Hébert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707357     DOI: 10.1016/j.cardiores.2007.07.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  4 in total

Review 1.  The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model.

Authors:  Valérie Boivin; Niklas Beyersdorf; Dieter Palm; Viacheslav O Nikolaev; Angela Schlipp; Justus Müller; Doris Schmidt; Vladimir Kocoski; Thomas Kerkau; Thomas Hünig; Georg Ertl; Martin J Lohse; Roland Jahns
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

3.  MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression.

Authors:  Laetitia Vanhoutte; Céline Guilbaud; Ruben Martherus; Caroline Bouzin; Bernard Gallez; Chantal Dessy; Jean-Luc Balligand; Stéphane Moniotte; Olivier Feron
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

4.  Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.

Authors:  Valérie Boivin-Jahns; Kerstin Uhland; Hans-Peter Holthoff; Niklas Beyersdorf; Vladimir Kocoski; Thomas Kerkau; Götz Münch; Martin J Lohse; Martin Ungerer; Roland Jahns
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.